#Serum Institute of India

October 5, 2023 by: web admin

WHO approves world’s 2nd malaria vaccine; cheaper & easier to produce

New Delhi: The World Health Organization (WHO) has given its endorsement to a cost-effective and highly efficient malaria vaccine developed through collaboration between the Pune-based …

April 9, 2022 by: web admin

Covishield, Covaxin price cuts to Rs 225 per dose for private hospitals

ANS: The prices of Covid vaccine, COVISHIELD (Serum Institute) and COVAXIN (Bharat Biotech) have been slashed for private hospitals. The price of the Covishield vaccine …

December 29, 2021December 29, 2021 by: web admin

Fight Against COVID: India approves 2 more Vaccines, 1 Pill

by Ashis Sinha Two more vaccinations and one antiviral medicine have received emergency use authorization from the Government of India to help fight the continuing …

December 14, 2021 by: web admin

COVID Vaccine for kids in next 6 months : Poonawalla

ANS I New Delhi: Covid-19 deterrent vaccine for children of age more than three years will be available in the country within next six months. …

August 6, 2021August 6, 2021 by: web admin

COVID jab for kids by Q1 of 2022: Poonawalla

JNS: Covovax, another COVID-19 vaccine, being manufactured by Serum Institute of India, will be launched in October for adults and for children by the first quarter …

May 14, 2021May 14, 2021 by: Ashis Sinha

Covishield 2nd dose interval increases to 12-16 weeks

ANS: The government has increased the intervals between two doses of Covishield to 12 to 16 weeks from the existing 6 to 8 weeks on Thursday. …

May 12, 2021 by: web admin

Covaxin gets approval for phase 2, 3 trials on 2-18 year-olds

ANS: An expert panel on Tuesday recommended Covaxin (COVID-19 vaccine) for phase-2 and phase-3 clinical trial on younger population aged between 2 to 18 years, …

May 4, 2021May 4, 2021 by: Ashis Sinha